<DOC>
	<DOCNO>NCT00067119</DOCNO>
	<brief_summary>Fistula Study : The objective study determine whether clopidogrel reduces early failure rate native AV fistula . Graft Study : The objective study determine whether Aggrenox ( Boehringer-Ingelheim ) prolongs primary unassisted patency newly create arteriovenous graft .</brief_summary>
	<brief_title>Vascular Access Clinical Trials Data Coordinating Center</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Aspirin , Dipyridamole Drug Combination</mesh_term>
	<criteria>Fistula Study Protocol Age 1821 depend state regulation Life expectancy least six month Chronic renal failure anticipate start hemodialysis within six month enrollment , current dialysis dependence Planned creation native upper extremity AV fistula The patient aspirin , patient aspirin myocardial infarction cerebrovascular accident within past 12 month . The patient expect stay participate dialysis facility least 6 month . The patient 's physician ( ) allow patient participate . Ability give inform consent . Women must pregnant , breastfeed , plan pregnant course study . The presence ongoing bleeding . The presence know bleed disorder ( e.g. , hemophilia von Willebrand 's disease ) . Recent bleed episode require transfusion within 12 week entry . The presence acute ulcer disease . Acute ulcer disease define new diagnosis peptic disease include esophagitis , gastritis , ulcer initiation treatment proton pump inhibitor , H2 blocker therapy Helicobacter pylorus within three month prior obtain consent . A condition prohibit discontinuation anticoagulant drug , aspirin , nonsteroidal antiinflammatory drug dudring six week study drug administration period . Use heparin dialysis allow . Required use oral intravenous glucocorticoid dose great equvalent prednisone 15 mg per day six week study drug administration period . Current unstable angina . Required use clopidogrel . Known hypersensitivity clopidogrel . Medical consideration make antiplatelet therapy dangerous . Current uncontrolled hypertension systolic blood pressure excess 200 mm Hg diastolic blood pressure excess 115 mm Hg time enrollment . Baseline platelet count less 75,000/mm3 . Known advanced liver disease decompensated cirrhosis , jaundice , ascites bleed varix . Current problem substance abuse . Concurrent participation another medical intervention trial . Anticipated noncompliance medical care base physician judgment . Patient refusal . Graft Study Protocol Inclusion criterion : Age 1821 depend state regulation Life expectancy least six month Chronic renal failure anticipate start hemodialysis within six month enrollment , current dialysis dependence A new plan AV graft place location purpose hemodialysis . ( Any type graft material configuration access acceptable ) . The patient expect stay participate dialysis facility least 6 month . The patient 's physician ( ) allow patient participate . Ability give inform consent . Women must pregnant , breastfeed , plan pregnant course study . The presence ongoing bleeding . The presence know bleed disorder ( e.g. , hemophilia von Willebrand 's disease ) . Recent bleed episode require transfusion within 12 week entry . The presence acute ulcer disease . Acute ulcer disease define new diagnosis peptic disease include esophagitis , gastritis , ulcer initiation treatment proton pump inhibitor , H2 blocker therapy Helicobacter pylorus within three month prior obtain consent . Known allergy adverse reaction Aggrenox study component ( dipyridamole aspirin ) . Required use warfarin , dipyridamole , nonsteroidal antiinflammatory drug antiplatelet agent aspirin . Current uncontrolled hypertension systolic blood pressure excess 200 mm Hg diastolic blood pressure excess 115 mm Hg . Baseline platelet count less 75,000/mm3 . Known advanced liver disease decompensated cirrhosis , jaundice , ascites bleed varix . Current problem substance abuse . Concurrent participation another medical intervention trial . Anticipated noncompliance medical care base physician judgment . Patient refusal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Graft Failure</keyword>
	<keyword>Access Blood Flow Monitoring</keyword>
	<keyword>Clinical Trial Vascular Access</keyword>
	<keyword>Fistula Failure</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Vascular Access</keyword>
</DOC>